Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Richard L Rauck, Neal E Slatkin, Nancy Stambler & Robert J Israel. (2019) Safety of oral methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain. Journal of Pain Research 12, pages 139-150.
Read now
Read now
Lynn R Webster & Robert J Israel. (2018) Oral methylnaltrexone does not negatively impact analgesia in patients with opioid-induced constipation and chronic noncancer pain. Journal of Pain Research 11, pages 1503-1510.
Read now
Read now
Shilan Mozaffari, Shekoufeh Nikfar & Mohammad Abdollahi. (2018) Methylnaltrexone bromide for the treatment of opioid-induced constipation. Expert Opinion on Pharmacotherapy 19:10, pages 1127-1135.
Read now
Read now
Articles from other publishers (23)
V. Andresen, G. Becker, T. Frieling, M. Goebel-Stengel, F. Gundling, A. Herold, M. Karaus, J. Keller, M. Kim, P. Klose, H. Krammer, M. E. Kreis, R. Kuhlbusch-Zicklam, J. Langhorst, P. Layer, R. Lenzen-Großimlinghaus, A. Madisch, H. Mönnikes, S. Müller-Lissner, D. Rubin, M. Schemann, J. Schwille-Kiuntke, A. Stengel, M. Storr, I. van der Voort, W. Voderholzer, T. Wedel, S. Wirz, H. Witzigmann & C. Pehl. (2022) Aktualisierte S2k-Leitlinie chronische Obstipation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie & Motilität (DGNM) – April 2022 – AWMF-Registriernummer: 021–019. Zeitschrift für Gastroenterologie 60:10, pages 1528-1572.
Crossref
Crossref
. 2022. Arzneimitteltherapie in der Palliativmedizin. Arzneimitteltherapie in der Palliativmedizin
511
774
.
Roberto De Giorgio, Furio Massimino Zucco, Giuseppe Chiarioni, Sebastiano Mercadante, Enrico Stefano Corazziari, Augusto Caraceni, Patrizio Odetti, Raffaele Giusti, Franco Marinangeli & Carmine Pinto. (2021) Management of Opioid-Induced Constipation and Bowel Dysfunction: Expert Opinion of an Italian Multidisciplinary Panel. Advances in Therapy 38:7, pages 3589-3621.
Crossref
Crossref
Solomon S. Liao, Neal E. Slatkin & Nancy Stambler. (2021) The Influence of Age on Central Effects of Methylnaltrexone in Patients with Opioid-Induced Constipation. Drugs & Aging 38:6, pages 503-511.
Crossref
Crossref
Ying-Ying Zhang, Rong Zhou & Wan-Jie Gu. (2021) Efficacy and Safety of Methylnaltrexone for the Treatment of Opioid-Induced Constipation: A Meta-analysis of Randomized Controlled Trials. Pain and Therapy 10:1, pages 165-179.
Crossref
Crossref
A. Jaber, S. Hemmer, R. Klotz, T. Ferbert, C. Hensel, C. Eisner, Y. M. Ryang, P. Obid, K. Friedrich, W. Pepke & M. Akbar. (2020) Bowel dysfunction after elective spinal surgery: etiology, diagnostics and management based on the medical literature and experience in a university hospitalDarmfunktionsstörung nach elektiver Wirbelsäulenoperation: Ätiologie, Diagnostik und Management nach der aktuellen Literatur und den Erfahrungen in einem Universitätsklinikum. Der Orthopäde 50:6, pages 425-434.
Crossref
Crossref
Nabil ALMouaalamy. (2021) Opioid-Induced Constipation in Advanced Cancer Patients. Cureus.
Crossref
Crossref
Charles E. Argoff. (2020) Opioid-induced Constipation. The Clinical Journal of Pain 36:9, pages 716-722.
Crossref
Crossref
Guillaume Gourcerol & Antoine Lemaire. (2020) Prise en charge de la constipation induite par les opioïdes : regards croisés d’un gastroentérologue et d’un médecin de la douleur. Douleurs : Évaluation - Diagnostic - Traitement 21:4, pages 147-154.
Crossref
Crossref
Erlania do Carmo Freitas, Geslaney Reis da Silva, Rudval Souza da Silva, Rita Narriman Silva de Oliveira Boery & Maria Patricia Milagres. (2020) Opioid-induced constipation in palliative care: state of the art. Revista de Pesquisa Cuidado é Fundamental Online, pages 1116-1124.
Crossref
Crossref
Bruce H Chamberlain, Michelle Rhiner, Neal E Slatkin, Nancy Stambler & Robert J Israel. (2020) Subcutaneous methylnaltrexone for opioid-induced constipation in advanced-illness patients with or without active cancer. Pain Management 10:2, pages 73-84.
Crossref
Crossref
Kirbylee K. Nelson, Mark A. Schattner & Robin B. Mendelsohn. (2019) Methylnaltrexone is safe in cancer patients with peritoneal carcinomatosis. Scientific Reports 9:1.
Crossref
Crossref
Adam D Farmer, Asbjørn M Drewes, Giuseppe Chiarioni, Roberto De Giorgio, Tony O'Brien, Bart Morlion & Jan Tack. (2019) Pathophysiology and management of opioid‐induced constipation: European expert consensus statement. United European Gastroenterology Journal 7:1, pages 7-20.
Crossref
Crossref
John M. Streicher & Edward J. Bilsky. (2017) Peripherally Acting μ-Opioid Receptor Antagonists for the Treatment of Opioid-Related Side Effects: Mechanism of Action and Clinical Implications. Journal of Pharmacy Practice 31:6, pages 658-669.
Crossref
Crossref
P.J. Larkin, N.I. Cherny, D. La Carpia, M. Guglielmo, C. Ostgathe, F. Scotté & C.I. Ripamonti. (2018) Diagnosis, assessment and management of constipation in advanced cancer: ESMO Clinical Practice Guidelines. Annals of Oncology 29, pages iv111-iv125.
Crossref
Crossref
Adam D Farmer, Caroline Bruckner Holt, Thomas J Downes, Eugenio Ruggeri, Sara Del Vecchio & Roberto De Giorgio. (2018) Pathophysiology, diagnosis, and management of opioid-induced constipation. The Lancet Gastroenterology & Hepatology 3:3, pages 203-212.
Crossref
Crossref
. 2018. Arzneimitteltherapie in der Palliativmedizin. Arzneimitteltherapie in der Palliativmedizin
447
696
.
Mellar P. Davis. 2018. The MASCC Textbook of Cancer Supportive Care and Survivorship. The MASCC Textbook of Cancer Supportive Care and Survivorship
17
35
.
Hong Yang & Tonghui Ma. (2017) Luminally Acting Agents for Constipation Treatment: A Review Based on Literatures and Patents. Frontiers in Pharmacology 8.
Crossref
Crossref
J. Tack, H. Boardman, P. Layer, I. Schiefke, D. Jayne, C. Scarpignato, M. Fox, T. Frieling, P. Ducrotte, S. Hamdy, K. Gill, C. Ciriza de los Rios, R. Felt-Bersma, D. De Looze, V. Stanghellini, A. Mohr Drewes, M. Simrén, C. Pehl, T. Hoheisel, A. Leodolter, E. Rey, J. Dalrymple & A. Emmanuel. (2017) An expert consensus definition of failure of a treatment to provide adequate relief (F-PAR) for chronic constipation - an international Delphi survey. Alimentary Pharmacology & Therapeutics 45:3, pages 434-442.
Crossref
Crossref
Kirby Welston & Dianne May. 2017. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions
373
387
.
Allen A. Lee & William L. Hasler. (2016) Opioids and GI Motility—Friend or Foe?. Current Treatment Options in Gastroenterology 14:4, pages 478-494.
Crossref
Crossref
Wojciech Leppert & Jaroslaw Woron. (2016) The role of naloxegol in the management of opioid-induced bowel dysfunction. Therapeutic Advances in Gastroenterology 9:5, pages 736-746.
Crossref
Crossref